Skip to content
10-Q

Quarterly Report

Sio Gene Therapies Inc.

0001636050-22-000040

← back to feed
Filed
Aug 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Aug 9, 2022 73.98M sh
Shares Diluted Q1 2023 · Jun 30, 2022 73.77M sh
Shares Diluted Q1 2023 · Jun 30, 2021 72.86M sh
Operating Cash Flow Q1 2023 · Jun 30, 2022 −$8.68M
Operating Cash Flow Q1 2023 · Jun 30, 2021 −$12.65M
Cash And Equivalents Q1 2023 · Jun 30, 2022 $54.77M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $63.73M
Cash And Equivalents Q1 2023 · Jun 30, 2021 $110.98M
Cash And Equivalents Q1 2023 · Mar 31, 2021 $118.99M
Stockholders Equity Q1 2023 · Jun 30, 2022 $51.78M
Stockholders Equity Q1 2023 · Mar 31, 2022 $60.35M
Stockholders Equity Q1 2023 · Jun 30, 2021 $113.3M
Stockholders Equity Q1 2023 · Mar 31, 2021 $123.37M
Current Liabilities Q1 2023 · Jun 30, 2022 $9.15M
Current Liabilities Q1 2023 · Mar 31, 2022 $13M
Total Liabilities Q1 2023 · Jun 30, 2022 $10.7M
Total Liabilities Q1 2023 · Mar 31, 2022 $14.73M
Current Assets Q1 2023 · Jun 30, 2022 $59.13M
Current Assets Q1 2023 · Mar 31, 2022 $71.74M
Total Assets Q1 2023 · Jun 30, 2022 $62.48M
Total Assets Q1 2023 · Mar 31, 2022 $75.08M
Eps Diluted Q1 2023 · Jun 30, 2022 −$0.11
Eps Diluted Q1 2023 · Jun 30, 2021 −$0.16
Eps Basic Q1 2023 · Jun 30, 2022 −$0.11
Eps Basic Q1 2023 · Jun 30, 2021 −$0.16
Sga Expense Q1 2023 · Jun 30, 2022 $2.99M
Sga Expense Q1 2023 · Jun 30, 2021 $3.86M
Rd Expense Q1 2023 · Jun 30, 2022 $5.54M
Rd Expense Q1 2023 · Jun 30, 2021 $8.06M
Net Income Q1 2023 · Jun 30, 2022 −$8.41M
Net Income Q1 2023 · Mar 31, 2022 −$71.9M
Net Income Q1 2023 · Jun 30, 2021 −$11.87M
Operating Income Q1 2023 · Jun 30, 2022 −$8.41M
Operating Income Q1 2023 · Jun 30, 2021 −$11.9M